Date |
Subject |
Details |
2024/04/23 |
Taiwan MOHW has approved a new version of thecollaborative autologous Natural Killer cell therapyproject by the Company and Hualien Tzu Chi Hospital |
20240423 |
2024/04/10 |
Announcement Completion of Cancellation of NewlyIssued Restricted Employee Shares and Relevant Changesin Registration |
20240410 |
2024/03/29 |
The Ministry of Health and Welfare has approvedthe collaborative autologous Gamma-Delta T cell therapyproject by the Company and Chi Mei Hospital, Liouying |
20240329 |
2024/03/26 |
Taiwan MOHW has approved a new version of thecollaborative autologous Natural Killer cell therapyproject by the Company and Changhua Christian Hospital |
20240326 |
2024/03/20 |
Taiwan MOHW has approved a New Version of thecollaborative autologous Natural Killer cell therapyproject by the Company and Chi Mei Hospital, Liouying |
20240320 |
2024/03/12 |
Announcement to explain the difference between thecompany’s consolidated monthly operating incomedeclaration for 12/2024 and accountants audited numbers. |
20240312 |
2024/03/11 |
Announcement to explain the difference between thecompany’s consolidated monthly operating incomedeclaration for 12/2024 and accountants audited numbers. |
20240311-6 |
2024/03/11 |
The Board of Directors has resolved not to distributedividends |
20240311-5 |
2024/03/11 |
The Company’s board of directors resolvedto convene 2024 General Shareholder’s meeting |
20240311-4 |
2024/03/11 |
Appointment of our company’s new ChiefScientific Officer |
20240311-3 |
2024/03/11 |
The Company’s Board of Directors has resolvedto redeem and cancel the restricted stocks issued toemployees |
20240311-2 |
2024/03/11 |
The Company’s 2023 consolidated financialstatements have been approved by the Board of Directors |
20240311-1 |
2024/02/29 |
Our company has applied to the Taiwan Food and DrugAdministration (TFDA) for Phase I/II clinical trial ofallogeneic natural killer cells (Magicell-NK) |
20240229 |
2024/02/16 |
The Ministry of Health and Welfare has approved the collaborative autologous Gamma-Delta T cell therapy project by the Company and Changhua Christian Hospital |
20240216 |
2024/02/07 |
Signing of the sales cooperation agreementfor the new drug OBP-301 in Japan. |
20240207 |
2024/01/30 |
Announcement of Important Resolutions by the Board of Directors of Our Company |
20240130 |
2024/01/11 |
Approved the collaborative autologous Gamma-Delta T cell therapy project by the Company and Taichung Tzu Chi Hospital |
20240111 |